MELBOURNE, Australia and INDIANAPOLIS — November 5, 2025 — Leads & Copy — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) will participate in the UBS Global Healthcare Conference in Palm Beach, FL, and the Jefferies Global Healthcare Conference in London.
Kevin Richardson, Chief Executive Officer, Precision Medicine, will engage in a fireside chat with UBS on Monday, November 10, 2025, at 12:30 pm EST. Richard Valeix, Chief Executive Officer, Therapeutics, will participate in a similar chat with Jefferies on Tuesday, November 18, 2025, at 10 am GMT.
Both sessions will be webcast live via Telix’s Investor Relations website. Registration details are available at https://ir.telixpharma.com/events-presentations.
Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com
Annie Kasparian
Telix Pharmaceuticals Limited
Director Investor Relations and Corporate Communications
Email: annie.kasparian@telixpharma.com
Source: Telix Pharmaceuticals Limited
